CAMP4 Therapeutics Corporation (CAMP)
(Delayed Data from NSDQ)
$10.50 USD
+1.40 (15.38%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $10.52 +0.02 (0.19%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth NA Momentum NA VGM
View All Zacks #1 Ranked StocksCAMP4 Therapeutics Corporation (CAMP) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
|---|---|---|---|
| $19.33 | $23.00 | $17.00 | 112.42% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for CAMP4 Therapeutics Corporation comes to $19.33. The forecasts range from a low of $17.00 to a high of $23.00. The average price target represents an increase of 112.42% from the last closing price of $9.10.
Analyst Price Targets (3 )
Broker Rating
CAMP4 Therapeutics Corporation currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to no recommendation a month ago.
Of the four recommendations deriving the current ABR, four are Strong Buy, representing 100% of all recommendations. There was no Strong Buy or Buy recommendation a month ago.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 4 | NA | NA | NA | NA |
| Buy | 0 | NA | NA | NA | NA |
| Hold | 0 | NA | NA | NA | NA |
| Sell | 0 | NA | NA | NA | NA |
| Strong Sell | 0 | NA | NA | NA | NA |
| ABR | 1.00 | NA | NA | NA | NA |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 11/5/2024 | William Blair | Myles R Minter | Not Available | Strong Buy |
| 11/5/2024 | SVB Securities | Mani Foroohar | Not Available | Strong Buy |
| 11/5/2024 | Piper Sandler | Edward A Tenthoff | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 1.00 |
| ABR (Last week) | NA |
| # of Recs in ABR | 4 |
| Average Target Price | $19.33 |
| LT Growth Rate | NA |
| Industry | Medical - Biomedical and Genetics |
| Industry Rank by ABR | 89 of 252 |
| Current Quarter EPS Est: | -0.80 |
CAMP FAQs
CAMP4 Therapeutics Corporation (CAMP) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for CAMP4 Therapeutics Corporation (CAMP) is $19.33. The current on short-term price targets is based on 3 reports.
The forecasts for CAMP4 Therapeutics Corporation (CAMP) range from a low of $17 to a high of $23. The average price target represents a increase of $112.42 from the last closing price of $9.10.
The current UPSIDE for CAMP4 Therapeutics Corporation (CAMP) is 112.42%
Based on short-term price targets offered by three analysts, the average price target for CAMP4 Therapeutics Corporation comes to $19.33. The forecasts range from a low of $17.00 to a high of $23.00. The average price target represents an increase of 112.42% from the last closing price of $9.10.